VOYXACT: payments to doctors
Payments that named VOYXACT as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $81K
- Providers
- 1,439
- Transactions
- 1,659
- Average per transaction
- $49
The per-transaction average — $49 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 1,439 providers the average total is $56, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | $74,591 | 92.5% |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | $6,039 | 7.5% |